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To quantify the risk and types of sequelae attributable 
to prior enteric infections, we undertook a population-based 
retrospective cohort study using linked administrative re-
cords. The risk for ﬁ   rst-time hospitalization for sequelae 
was modeled by using Cox proportional regression analy-
sis controlling for other health and sociodemographic fac-
tors. We identiﬁ  ed a signiﬁ  cant increase of 64% in the rate 
of  ﬁ   rst-time hospitalization for sequelae for persons with 
prior enteric infections: 52% for intragastrointestinal seque-
lae and 63% for extragastrointestinal sequelae compared 
with ﬁ  rst-time hospitalization for those without prior infec-
tion. Extragastrointestinal sequelae occurred predominantly 
during the ﬁ  rst 5 years after ﬁ  rst-time enteric infection. In 
contrast, most intragastrointestinal sequelae occurred >10 
years later. Infective gastroenteritis during childhood or ado-
lescence increases the risk for ﬁ  rst-time hospitalization for 
intragastrointestinal and extragastrointestinal disease over 
the 2 decades after ﬁ  rst-time enteric infection, highlighting 
the importance of identifying ways of reducing the incidence 
of such infections.
G
astroenteritis is a common illness worldwide and has 
a considerable effect on the public health of commu-
nities and health systems that provide care. In developing 
countries, gastrointestinal infection is a major cause of 
death, claiming ≈2 million lives each year among children 
<5 years of age (1). By contrast, most episodes of gastro-
enteritis in industrialized nations do not cause serious, im-
mediate, adverse sequelae but remain common, especially 
in the young (2,3). In addition to the immediate health 
concerns associated with gastroenteritis, subsequent me-
dium- to long-term adverse sequelae have been described. 
A range of gastrointestinal, rheumatologic, neurologic, and 
skin and lung conditions have been associated with previ-
ous exposure to enteric infections (4–13).
Most of these data are from case reports and small-
sample cross-sectional studies; however, several recent 
short-term longitudinal studies have provided estimates of 
the incidence of adverse health events after enteric infec-
tions (8,14,15). These studies suggest that the increase in 
risk for sequelae is considerable. For example, in a follow-
up cohort study of a community exposed to a waterborne 
disease outbreak, the relative risks for chronic gastrointes-
tinal symptoms, arthralgia, and psychiatric conditions were 
2.4, 1.4, and 2.0, respectively (16). However, the long-term 
population-based extent of sequelae from prior enteric 
infection has remained unclear because previous studies 
have not adjusted for confounding variables, follow-up was 
short-term (8), evaluations were taken when populations 
were exposed to an outbreak of water-borne disease (8,14), 
and adverse events were either identiﬁ  ed by self-reporting 
(8,14) or compared with expected, but not measured, rates 
of events in the general population (15).
The Western Australia Data Linkage System (WADLS) 
provided a unique opportunity to undertake a robust, long-
term, longitudinal study of the sequelae associated with 
notiﬁ  able enteric infections in the general population. This 
system enables capture of health events in persons previ-
ously exposed and not exposed to an enteric infection. Our 
goal was to quantify the rate, risk, and type of sequelae 
attributable to previous childhood and adolescent exposure 
to enteric infections that lead to hospitalization, controlling 
for other health and sociodemographic factors.
Methods
This retrospective, population-based, longitudinal cohort 
study linked routinely collected administrative records from 
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the Western Australian notiﬁ  able infectious diseases data-
base (NIDD) with data contained in the Western Australian 
hospital morbidity data system (HMDS). Western Austra-
lian death notiﬁ  cations routinely collected under the Western 
Australian State government statute were also linked.
Study Participants and Sources of Data
The cohort comprised all persons having a Western 
Australia birth notiﬁ   cation during January 1, 1985–De-
cember 31, 2000. For each person, the following records 
were extracted by the WADLS: 1) NIDD records of any 
enteric infection from birth through December 31, 2007, 
and including encrypted patient identiﬁ  cation, sex, age at 
notiﬁ  cation, date of notiﬁ  cation or onset, species causing 
enteric infection, and residence recorded as postal code at 
notiﬁ  cation; 2) HMDS records of all separations (discharge 
from hospital) from any Western Australia hospital (pub-
lic and private) from December 31, 2007, and comprising 
encrypted patient identiﬁ  cation, age at hospitalization, sex, 
Aboriginality, date of admission, and International Classi-
ﬁ  cation of Diseases, 9th Revision, code for principal and 
additional diagnoses; and 3) any death notiﬁ  cation for the 
person, comprising encrypted patient identiﬁ  cation, sex, 
age at death, and date of death.
Deﬁ  nition of Prior Infection 
Each person was assigned to 1 of 2 mutually exclusive 
groups. The exposed group was deﬁ  ned as persons with any 
past enteric infection. More speciﬁ  cally, these were past in-
fections notiﬁ  ed on the NIDD or a past hospitalization for 
an enteric infection recorded on the HMDS where no NIDD 
notiﬁ  cation was present. The unexposed group (those with 
no prior infection) comprised persons for whom the NIDD 
and HMDS had no notiﬁ  cations pertaining to any form of 
gastroenteritis.
For the exposed group, the date of past infection was 
the date of onset recorded on the NIDD notiﬁ  cation or the 
date of admission recorded on the HMDS for a ﬁ  rst-time 
enteric infection. Using a birth cohort methodology, the un-
exposed group (no prior infection) would be expected to be 
followed up for longer (birth to outcome) than the exposed 
group (prior infection to outcome). To reduce this bias, 
each person in the unexposed group was given a proxy date 
of prior infection achieved by randomly assigning the ex-
posure dates observed in the exposed group to nonexposed 
persons.
Deﬁ  nition of Outcome 
We were interested in outcomes (sequelae) that result-
ed in hospitalization. Therefore, the outcome was deﬁ  ned as 
a ﬁ  rst-time hospitalization and a diagnosis of any sequelae 
of interest recorded as either the principal or co-diagnosis 
at any time from birth to death or end of follow-up. The se-
quelae of interest were further divided into 2 broad groups 
(intraintestinal and extraintestinal conditions) (online Ap-
pendix Table 1, www.cdc.gov/EID/content/16/9/1440-
appT1.htm).
To differentiate persons with a ﬁ  rst-time hospitaliza-
tion for the sequelae of interest after a NIDD notiﬁ  cation 
(incident cases) from those with a previous hospitalization 
for a sequelae before exposure (prevalent cases), we exam-
ined HMDS records dating back to birth. Prevalent cases 
were excluded from the study. For each person, the follow-
up time, or time at risk for sequelae (years, or part thereof) 
was enumerated from the date of prior infection, or proxy 
date of prior infection for unexposed persons, to admission 
date for the sequelae of interest, date of death, or December 
31, 2007 (end of follow-up), as appropriate. 
Determination of Socioeconomic 
Status and Residence
Socioeconomic status and residence were also deter-
mined from existing records. Published Socio-Economic 
Indexes for Areas (Index of Relative Social Disadvantage) 
(17) and Accessibility/Remoteness Index of Australia scores 
(18) were mapped to the postal codes of persons at birth.
Presence of Preexisting Concurrent Conditions 
The presence of preexisting concurrent conditions 
was identiﬁ  ed by using the International Classiﬁ  cation of 
Diseases, 9th Revision, codes for hospital separations. The 
Multipurpose Australian Comorbidity Scoring System (19) 
was used to determine any hospitalization for a concur-
rent illness for each person at the outcome, death, or end 
of follow-up.
Analysis
Data were analyzed by using SPSS software, version 
14 (SPSS Inc., Chicago, IL, USA). Incidence rates for in-
dividual enteric infections and types of sequelae were cal-
culated by using the number of events as the numerator and 
the follow-up time as the denominator.
After determining that the structure of the data was 
appropriate by testing the proportional hazards assump-
tion (20), we used the Cox proportional hazards regression 
model to conduct survival analyses. We examined the risk 
for ﬁ  rst-time hospitalization for any sequelae, intragastro-
intestinal sequelae, and extragastrointestinal sequelae over 
time by using Cox proportional hazards regression models, 
in which we compared the risk for ﬁ  rst-time hospitaliza-
tion among persons with prior enteric infection with that of 
those who had no prior infection. These models were ad-
justed for factors that may have inﬂ  uenced the probability 
of ﬁ  rst-time hospitalization occurring, i.e., sex, indigenous 
status, year of birth, age at exposure or proxy, singleton 
versus multiple birth status, weight at birth, hospital birth 
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versus nonhospital birth, mother’s region of birth, father’s 
region of birth, socioeconomic status, accessibility to ser-
vices, and previous hospitalization for comorbidity.
When possible, Cox proportional hazards models were 
also constructed separately by type of enteric infection. 
To determine which sociodemographic or disease factors 
were inﬂ  uential in sequelae development, separate survival 
models were also constructed for exposed and unexposed 
groups.
Attributable risk percent was used to estimate the pro-
portion of sequelae for which prior exposure to an enteric 
infection was a component cause. This attributable risk was 
calculated as the adjusted rate ratio (obtained from the Cox 
proportional hazards regression model) minus 1, divided 
by the adjusted rate ratio, multiplied by 100. Thus, we es-
timated the percentage of ﬁ  rst-time hospitalizations for se-
quelae in the exposed cohort that were attributable to being 
previously exposed to an enteric infection after controlling 
for known potential confounders.
Ethical Approval
The study was approved by The University of Western 
Australia’s Human Research Ethics Committee. All data 
were deidentiﬁ  ed before being provided to the researchers.
Results
Study Participants
Of the 336,401 persons who met the inclusion crite-
ria, 23,477 (7%) had at least 1 notiﬁ  cation for an enteric 
infection during the 22-year study period. Similar propor-
tions (<3% difference) of male patients, nonindigenous 
persons, singleton births, and hospital births were found in 
both groups (Table 1). For those with prior enteric infec-
tion, small birth-weight babies <3,000 grams were over-
represented (p<0.0001); normal birth-weight babies 3,001–
4,000 grams were underrepresented; and disadvantaged 
persons (socioeconomic status and accessibility to services; 
p<0.0001), persons having prior comorbidity (p<0.0001), 
and persons having prior hospitalization (p<0.0001) were 
overrepresented. The median year of birth for those with 
prior enteric infection was 1994, compared with 1992 for 
those with no prior enteric infection; however, the mean age 
at exposure or proxy was similar for both groups (2.9 years 
and 2.4 years, respectively). Mean survival to a ﬁ  rst-time 
hospitalization for any sequelae, death, or end of follow-up 
for persons with and without prior enteric infection was 8.6 
and 11 years, respectively (p<0.0001).
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Table 1. Sociodemographic characteristics and measures of preexisting health status for those with and without history of enteric
infection, Western Australia, Australia, January 1, 1985–December 31, 2000 
Characteristic History, no. (%), n = 23,477  No history, no. (%), n = 312,924  % Difference* 
Male sex  12,297 (52.4)  156,873 (50.1)  2.3
Not of indigenous status  19,872 (84.6)  272,226 (87.0)  –2.4
Singleton birth  22,867 (97.4)  305,028 (97.5)  –0.1
Hospital birth  22,382 (95.3)  298,919 (95.5)  –0.2
Weight at birth, g 
 <2,000  544 (2.3)  4,862 (1.6)  0.7
  2,001–3,000  5,114 (21.8)  58,256 (18.6)  3.2†
  3,001–4,000  14,550 (62.0)  205,289 (65.6)  –3.6† 
  4,001–5,000  2,005 (8.5)  31,705 (10.1)  –1.6
  >5,001  43 (0.2)  469 (0.1)  0.1
Socioeconomic status 
  Extremely advantaged   4,315 (18.4)  64,322 (20.6)  –2.2
  Advantaged  3,365 (14.3)  43,709 (14.0)  0.3
  Average  3,070 (13.1)  36,159 (11.6)  1.5
  Disadvantaged  5,653 (24.1)  61,379 (19.6)  4.5†
  Extremely disadvantaged  6,322 (26.9)  58,610 (18.7)  8.2†
Accessibility to services 
  Highly accessible   14,926 (63.6)  199,090 (63.6)  0
  Accessible  1,748 (7.4)  19,056 (6.1)  1.3
  Moderately accessible  2,042 (8.7)  19,836 (6.3)  2.4
  Remote  804 (3.4)  6,770 (2.2)  1.2
  Very remote  2,812 (12.0)  13,808 (4.4)  7.6†
Ever hospitalized for a comorbidity‡  22,561 (96.1)  254,745 (81.4)  14.7† 
Prior hospitalization‡  22,786 (97.0)  264,702 (84.6)  12.4† 
Hospitalization in first year of life‡  18,361 (78.2)  189,959 (60.7)  17.5† 
Hospitalization in first month of life‡  15,785 (67.2)  177,679 (56.8)  10.4† 
*Percentage with history – percentage without history.  
†p<0.0001. 
‡Excludes hospitalization for sequelae. Long-Term Health Risks after Gastroenteritis
Distribution of Sequelae
The highest rates of sequelae were observed for ex-
tragastrointestinal conditions: 2,407 and 977 per 100,000 
person-years for those with and without prior enteric infec-
tion, respectively (Table 2). Intragastrointestinal sequelae, 
in comparison, occurred less frequently (400 and 226 per 
100,000 person-years for those with and without prior en-
teric infection, respectively).
Risk for Hospitalization for First-time 
Sequelae According to Exposure Status
The rate of ﬁ  rst-time hospitalization increased signiﬁ  -
cantly for all outcomes analyzed; a slightly larger increase 
was found in risk for extragastrointestinal sequelae com-
pared with intragastrointestinal sequelae (Table 3). Some of 
the elevation in the crude rate ratios was reduced after ad-
justment for sociodemographic and preexisting health sta-
tus, which indicates confounding by these variables (online 
Appendix Table 2, www.cdc.gov/EID/content/16/9/1440-
appT2.htm), which indicates signiﬁ  cant confounding for 
most of the variables assessed with respect to any and ex-
tragastrointestinal sequelae. However, for intragastrointes-
tinal sequelae, only age, accessibility to services, born in 
hospital, mother’s region of birth, and hospitalization for 
a prior comorbidity signiﬁ  cantly affected the risk for hos-
pitalization for sequelae (online Appendix Table 2). The 
adjusted rate ratios showed an increased rate of hospital-
ization for any sequela of 64%, intragastrointestinal seque-
lae of 52%, and extragastrointestinal sequelae of 63% for 
persons with prior enteric infection. The attributable risk 
fractions indicated that 39% of ﬁ  rst-time hospitalizations 
for all sequelae (34% of intragastrointestinal and 39% of 
extragastrointestinal sequelae) were directly attributable to 
prior enteric infections.
Survivor Proﬁ  le
The survivor proﬁ  les for extragastrointestinal and in-
tragastrointestinal sequelae differed (Figure). Extragastroin-
testinal sequelae occurred predominantly in the ﬁ  rst 5 years 
after a ﬁ  rst-time enteric infection; thereafter, the survivor 
function curves did not change signiﬁ  cantly for the 2 groups. 
In contrast, the survivor function curves for intragastrointes-
tinal sequelae indicate little difference between those with 
and without prior enteric infection over the ﬁ  rst 10 years. 
After this time the survivor function curves deviate signiﬁ  -
cantly, suggesting that these sequelae mostly occur later. 
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Table 2. Number and rates of first-time intragastrointestinal and extragastrointestinal sequelae for those with and without history of 
enteric infection, Western Australia, January 1, 1985–December 31, 2005* 
Category of first-time sequelae 
History No  history 
Difference‡  No. (%)  Rate†  No. (%)  Rate† 
Extragastroiintestinal sequelae  5,045 (100.0)  2,407.1  34,425 (100.0)  976.6  1,430.5 
  Respiratory infections  2,535 (50.2)  1,209.5  14,750 (42.8)  418.5  791.1 
  Infections of the middle ear and mastoid  1,544 (30.6)  736.7  13,164 (38.2)  373.5  363.2 
  Cellulitis, osteomyelitis, and myositis  364 (7.2)  173.7  2,327 (6.8)  66.0 107.7 
  Fever, unknown origin  303 (6.0)  144.6  1,409 (4.1)  40.0 104.6 
  Upper and lower urinary tract infections  78 (1.5)  37.2 715 (2.1)  20.3 16.9
  Infections of lymphatic vessels  69 (1.4)  32.9 607 1.8)  17.2 15.7
  Inflammatory diseases of the CNS  35 (0.7)  16.7 194 (0.6)  5.5 11.2
  Arthropathies  39 (0.8)  18.6 275 (0.8)  7.8 10.8
  Endometriosis  18 (0.4)  8.6 146 (0.4)  4.1 4.4
  Orchitis and epididymitis  13 (0.3)  6.2 122 (0.4)  3.5 2.7
  Bacteremia  8 (0.2)  3.8 55 (0.2)  1.6 2.3
  Pilonidal cyst  38 (0.8)  18.1 600 (1.7)  17.0 1.1
  Thyroiditis  1 (0.0)  0.5 2 (0.0)  0.1 0.4
  Guillain-Barré syndrome  0 0.0 37 (0.1)  1.0 1.0 
  Cardiac infections  0 0.0 22 (0.1)  0.6 0.6 
Intragastrointestinal sequelae  1,267 (100.0)  400.3  9,385 (100.0)  226.2  174.2 
 Intestinal  obstruction,  diverticular  disease,
  irritable bowel syndrome/megacolon 
278 (21.9)  87.8 1,536 (16.4)  37.0 50.8
  Appendicitis  565 (44.6)  178.5  5,690 (60.6)  137.1  41.4
  Infections of the oral cavity and esophagus  103 (8.1)   32.5 333 (3.5)  8.0 24.5
  Enteritis, colitis and noninfective gastroenteritis 125 (9.9)  39.5 697 (7.4)  16.8 22.7
  Infections of the stomach and duodenum  122 (9.6)  38.5 684 (7.3)  16.5 22.1
  Peritonitis and ascites  16 (1.3)  5.1 25 (0.3)  0.6 4.5
  Cholecystitis  40 (3.2)  12.6 346 (3.7)  8.3 4.3
  Pancreatitis  18 (1.4)  5.7 74 (0.8)  1.8 3.9
*CNS, central nervous system.  
†Per 100,000 person-years. 
‡Rate for patients with history – rate for patients without history. RESEARCH
Type of Enteric Notiﬁ  cations and Risk for 
Sequelae by Type of Infection
Of the 23,477 ﬁ  rst-time notiﬁ  cations of enteric infec-
tion, the most frequently reported single deﬁ  ned causes 
were Campylobacter spp. (17%), viruses (17%), and Sal-
monella spp. (12%). Forty-two percent of notiﬁ  cations 
were identiﬁ  ed solely by using hospitalization records as 
“Enteritis and gastroenteritis, not otherwise speciﬁ  ed.” An 
additional 12% of notiﬁ  cations were of various other spe-
ciﬁ  c organisms. The risk proﬁ  le for intragastrointestinal 
and extragastrointestinal sequelae were similar for the most 
common infective pathogens (Table 4). The exception was 
for Salmonella infection, which did not confer an increased 
risk for intragastrointestinal sequelae.
Discussion
Our study showed that prior exposure to an enteric 
infection during childhood or adolescence increases the 
risk for a ﬁ  rst-time hospitalization for a wide range of in-
tragastrointestinal and extragastrointestinal illnesses by 
64% over 22 years of follow-up. Furthermore, 39% of 
ﬁ  rst-time hospitalizations for these illnesses were directly 
attributable to a previous enteric infection. The risk for 
extragastrointestinal sequelae was higher than that of in-
tragastrointestinal sequelae, and the time of onset for the 
2 categories of sequelae differed. Intragastrointestinal se-
quelae occurred much later after exposure than extragas-
trointestinal sequelae, a ﬁ  nding that has not been reported 
previously. 
We found that respiratory and middle ear infections 
were the largest contributors to the excess rate of extra-
gastrointestinal conditions. Appendicitis, the most com-
mon intragastrointestinal sequelae in this age-group, had 
a 23% increased risk in persons previously exposed to en-
teric infection. This association has previously been sug-
gested for Campylobacter infection (9). We also found a 
57% increase in risk for enteritis, colitis, and noninfective 
gastroenteritis, a diagnostic grouping that includes ulcer-
ative colitis and Crohn disease; again, this association has 
previously been made (7,8). However, contrary to previous 
studies that reported an association between enteric infec-
tion and subsequent disease (14,21–26), the ﬁ  ndings in our 
study suggest that risk increases over time, especially with 
regards to intragastrointestinal sequelae where the risk be-
comes greatest >10 years after onset of gastroenteritis in-
fections in children and adolescents.
Our ﬁ  ndings indicate that being male, indigenous, of 
low birthweight, and socioeconomically disadvantaged and 
being born outside the metropolitan area increases risk for 
developing the measured sequelae in exposed and unex-
posed persons (data not shown). However, we conﬁ  rmed 
that previous exposure to an enteric infection is an impor-
tant risk factor because after these factors are adjusted for, 
a 64% increase in risk for sequelae remains. We found that 
salmonellosis afforded no additional risk for intragastroin-
testinal sequelae but increased the risk for extragastroin-
testinal sequelae by 43%. With this exception, all common 
causes of infective gastroenteritis were equally represented 
as increasing the risk for sequelae.
This study has several strengths and limitations that 
warrant consideration when interpreting our results. A ma-
jor strength of the research was the use of linked birth, hos-
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Figure. Kaplan-Meier estimates of the adjusted survivor function 
with respect to any sequelae (A), intragastrointestinal sequelae (B), 
and extragastrointestinal sequelae (C) for those with and without 
prior enteric infection, Western Australia, Australia, January 1, 
1985–December 31, 2000.Long-Term Health Risks after Gastroenteritis
pital, death, and communicable disease notiﬁ  cations data 
obtained over a long time, which made available a compre-
hensive patient-based longitudinal dataset, as opposed to an 
events-based dataset. Data were of a routine administrative 
nature, and there was no likelihood of a Hawthorne effect 
(changes caused by participants being observed) or recall 
bias. The study covered the entire population of those born 
in Western Australia and therefore avoided challenges to 
external validity that arise when patient series are reported 
from selected institutions.
Our study incorporated an extensive amount of socio-
demographic and other health-related data, thus enabling 
adjustment of the models for a range of measurable con-
founding variables. We recognize that a variety of unmea-
surable, potentially confounding, sociodemographic fac-
tors may not have been completely captured by this study. 
However, given the magnitude of the increase in risk for 
sequelae observed for those exposed, all of this increase 
in risk would be unlikely to be removed if these potential 
confounders could be adjusted for. One way to have ad-
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Table 3. Number and rate of first-time hospitalizations, rate ratios, and attributable risk for sequelae for those with and without history 
of enteric infection, Western Australia, Australia, January 1,1985–December 31, 2000* 
Type of sequelae 
First-time hospitalizations 
Crude rate ratio, 
RR (95% CI) 
Adjusted† rate 





With history  No history 
No. Rate No. Rate 
Any   5,634  27.8 41,054  11.8 2.36 (2.28–2.41)  1.64 (1.59–1.67)  39 0.05
Intragastrointestinal  1,267  4.0 9,385  2.3 1.77 (1.67–1.88)  1.52 (1.42–1.62)  34 0.04
Extragastrointestinal  5,045  24.1 34,425  9.8 2.46 (2.39–2.54)  1.63 (1.57–1.68)  39 0.08
*Rates are per 100,000 person-years. RR, relative risk; CI, confidence interval; AR, attributable risk. 
†Multivariate Cox regression estimating the adjusted rate ratio of first-time hospitalization for any, intragastrointestinal, and extragastrointestinal sequelae. 
Adjusted for gender, indigenous status, year of birth, age at exposure or proxy, singleton, weight at birth, hospital birth, mother’s region of birth, father’s 
region of birth, socioeconomic status, accessibility to services and previous hospitalization for comorbidity. 
‡Proportion of first-time hospitalizations for sequelae where previous exposure to an enteric infection was a component cause. 
§Pseudo R
2. As explained by Hosmer and Lemeshow (20), a measure analogous to R
2 would be useful as a measure of Cox regression model 
performance; however, although a pseudo R
2can be calculated the values obtained are often low because of  the censored nature of the data even 
though the model is adequate. In our models the R
2 values were 0.05, 0.04, and 0.08 for the 3 models (any, intragastrointestinal, and 
extragastrointestinal), respectively. The models generated were population-based descriptive models, which aimed to evaluate the average effect on 
survival to first-time hospitalization with the outcome of interest adjusted for known and measurable confounders, rather than predict the probability of 
survival for a specified individual. Thus, the most important assessment criteria for evaluating the appropriateness of a descriptive Cox regression model 
is that the proportional hazards assumption is not violated and the overall model is significant. In all of our models the proportional hazards assumption 
was tested and found not to be violated and the overall model significance was Prob > F
2 <0.00005. 
Table 4. Crude and adjusted rate ratio and attributable risk for first-time hospitalization for sequelae, by type of prior infection and 
classification of sequelae, Western Australia, Australia, January 1,1985–December 31, 2000* 
Type of sequelae and type of prior 
infection
Crude rate ratio, RR 
(95% CI) 
Adjusted† rate ratio, RR 
(95% CI)  Adjusted AR, %‡  Goodness of fit§ 
Any  0.05
  Campylobacteriosis  1.56 (1.43–1.69)  1.52 (1.39–1.66)  34
  Giardiasis  2.10 (1.91–2.31)  1.51 (1.36–1.68)  34
  Salmonellosis  1.86 (1.71–2.03)  1.39 (1.26–1.53)  28
  Viral enteritis  2.10 (1.96–2.24)  1.68 (1.56–1.81)  40
  Enteritis/gastroenteritis NOS  2.60 (2.51–2.70)  1.76 (1.70–1.84)  43
Extragastrointestinal  0.07
  Campylobacteriosis  1.50 (1.37–1.64)  1.45 (1.32–1.60)  31
  Giardiasis  2.26 (2.04–2.49)  1.54 (1.38–1.73)  35
  Salmonellosis  2.01 (1.85–2.21)  1.43 (1.29–1.58)  31
  Viral enteritis  2.12 (1.98–2.27)  1.63 (1.51–1.76)  39
  Enteritis/gastroenteritis NOS  2.69 (2.58–2.80)  1.74 (1.66–1.82)  43
Intragastrointestinal  0.02
  Campylobacteriosis  1.76 (1.51–2.05)  1.64 (1.40–1.93)  39
  Giardiasis  1.37 (1.10–1.68)  1.29 (1.03–1.61)  23
  Salmonellosis  1.09 (0.87–1.34)  1.00 (0.79–1.25)  0
  Viral enteritis  1.99 (1.72–2.29)  1.56 (1.34–1.85)  36
  Enteritis/gastroenteritis NOS  2.03 (1.88–2.20)  1.66 (1.52–1.81)  40
*RR, relative risk; CI, confidence interval; AR, attributable risk; NOS, not otherwise specified. 
†Multivariate Cox regression estimating the adjusted rate ratio of first-time hospitalization for any, intragastrointestinal, and extragastrointestinal sequelae. 
Adjusted for gender,indigenous status, year of birth, age at exposure or proxy, singleton, weight at birth, hospital birth, mother’s region of birth, father’s 
region of birth, socioeconomic status, accessibility to services, and previous hospitalization for comorbid conditions. 
‡Proportion of first-time hospitalizations for sequelae where previous exposure to the specified enteric infection was a component cause. 
§Pseudo R
2. In our models, the R
2 values were 0.05, 0.07, and 0.02 for the 3 sets of models (any, extragastrointestinal, and intragastrointestinal) 
respectively. In all models the proportional hazards assumption was tested and found not to be violated, and the overall model significance was Prob > F
2
<0.00005. RESEARCH
justed for unmeasurable factors would have been to restrict 
the study population to those hospitalized for a condition 
unrelated to the exposure (prior enteric infection) and the 
outcome, such as injury. However, this adjustment would 
have dramatically reduced the sample size, and hence the 
power of the study, and would have substantially limited 
generalizability.
Substantial errors in our dataset are unlikely because 
classiﬁ  cation regimens were applied consistently through-
out; validation research on the WADLS (27) has shown 
that missing data items are uncommon (<1%) and that the 
technical performance of the linkage between records is 
high (>99% speciﬁ  city and sensitivity). Accordingly, our 
data are a highly robust representation of the population 
studied, based on usual hospital admission practices and 
outcomes of persons after notiﬁ  cation of an enteric infec-
tion within the Australian healthcare system. 
Our study relied on the use of notiﬁ  cations or hospi-
talization for enteric infections; not all enteric infections 
are notiﬁ  ed. Enteric infections that cause only mild symp-
toms may go unreported either because the person may 
not seek medical advice or because a medical practitioner 
may not undertake conﬁ  rmatory testing (28). Our conclu-
sions are based on an assumption that a similar proportion 
of underreporting of enteric infection occurred for those 
classiﬁ  ed with and without prior infection. Because noti-
ﬁ  cation of enteric infection is more likely for moderate to 
severe illness, our results pertain to this group rather than 
all enteric infections. This restriction limits generalizabil-
ity (the range of persons not studied directly to whom the 
results can be applied), although it does not affect the va-
lidity of our results.
Sequelae in this study were captured as a ﬁ  rst-time hos-
pitalization for the condition of interest. Thus, some seque-
lae that produced only mild symptoms not requiring hospi-
talization were not captured, producing an underestimation 
of ﬁ  rst-time sequelae. We evaluated the risk for ﬁ  rst-time 
hospitalization for sequelae rather than incidence of seque-
lae per se. Although this type of evaluation is a limitation, 
the sequelae that have been measured are of clinical impor-
tance by virtue of the need for hospitalization.
We used the Western Australian birth register as the 
method of identiﬁ  cation. These data enabled comprehen-
sive inclusion of all persons born in the state, enabling 
complete capture of ﬁ  rst-time enteric infections and out-
come, within the deﬁ  nitions discussed above. The birth 
register also provided information about parents’ place of 
birth, enabling these potential confounding variables to be 
evaluated when constructing the models. However, the use 
of a birth cohort did not permit the inclusion of internation-
al or interstate migrants. Again, this exclusion potentially 
limits the generalizability of our ﬁ  ndings because migrants 
may have different risks of developing sequelae than non-
migrants. Inclusion of migrants in this study would have 
created difﬁ  culty capturing exposure and outcome data be-
cause their health records were not available before indi-
viduals became residents of Western Australia.
Although our study estimated the magnitude of the 
increased risk for illness attributable to prior enteric infec-
tions, we cannot explain why enteric infection during child-
hood or adolescence subsequently increases the risk for ill-
ness. Genetic susceptibility for disease, combined with an 
environmental trigger, has previously formed the basis for 
explaining this risk for conditions with an autoimmune ba-
sis, such as inﬂ  ammatory bowel disease (15,21). Our ﬁ  nd-
ing of an increased risk for nongastrointestinal infections is 
more difﬁ  cult to account for by autoimmune mechanisms. 
We speculate that increased risk for nongastrointestinal 
infections may result from dysregulated immunity, par-
ticularly in the short to medium term, after gastroenteritis, 
brought about by the inﬂ  uence of enteric infection on the 
gastrointestinal immune system.
Medium- to long-term adverse health implications of 
gastroenteritis must be accurately assessed so that appropri-
ate risk-management strategies can be developed for those 
exposed to enteric infections. Recent reports have described 
the effect of acute gastrointestinal infections in industrial-
ized countries, such as Australia (2,28) and Canada (29). 
These investigations have focused on identifying rates of, 
and risk factors for, infectious gastrointestinal illness with 
the goal of informing public health policy and planning. 
The need to investigate the impact of long-term sequelae of 
infectious gastrointestinal illness has also been highlighted 
(29). According to our data, sequelae are clearly substantial 
and provide another reason for trying to reduce the inci-
dence of acute gastrointestinal infection worldwide.
Our study shows that enteric infection during childhood 
or adolescence increases the risk for ﬁ  rst-time hospitaliza-
tion for a range of intragastrointestinal and extragastroin-
testinal disease for 2 decades after onset of infection. This 
risk is greater, and occurs earlier, for extragastrointestinal 
sequelae than for intragastrointestinal sequelae. Our results 
highlight the importance of identifying ways of reducing 
such infections.
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